Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.
Kahkoska AR, Abrahamsen TJ, Alexander GC, Bennett TD, Chute CG, Haendel MA, Klein KR, Mehta H, Miller JD, Moffitt RA, Stürmer T, Kvist K, Buse JB; N3C Consortium. Kahkoska AR, et al. Among authors: mehta h. Diabetes Care. 2021 Jul;44(7):1564-1572. doi: 10.2337/dc21-0065. Epub 2021 Jun 16. Diabetes Care. 2021. PMID: 34135013 Free PMC article.
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
Mehta HB, An H, Andersen KM, Mansour O, Madhira V, Rashidi ES, Bates B, Setoguchi S, Joseph C, Kocis PT, Moffitt R, Bennett TD, Chute CG, Garibaldi BT, Alexander GC; National COVID Cohort Collaborative (N3C). Mehta HB, et al. Ann Intern Med. 2021 Oct;174(10):1395-1403. doi: 10.7326/M21-0857. Epub 2021 Aug 17. Ann Intern Med. 2021. PMID: 34399060 Free PMC article.
Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study.
Bramante CT, Johnson SG, Garcia V, Evans MD, Harper J, Wilkins KJ, Huling JD, Mehta H, Alexander C, Tronieri J, Hong S, Kahkoska A, Alamgir J, Koraishy F, Hartman K, Yang K, Abrahamsen T, Stürmer T, Buse JB; N3C core authors. Bramante CT, et al. Among authors: mehta h. PLoS One. 2022 Nov 17;17(11):e0271574. doi: 10.1371/journal.pone.0271574. eCollection 2022. PLoS One. 2022. PMID: 36395143 Free PMC article.
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes.
Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, Laraway B, Antonescu C, Coleman B, Gargano M, Wilkins KJ, Cappelletti L, Fontana T, Ammar N, Antony B, Murali TM, Caufield JH, Karlebach G, McMurry JA, Williams A, Moffitt R, Banerjee J, Solomonides AE, Davis H, Kostka K, Valentini G, Sahner D, Chute CG, Madlock-Brown C, Haendel MA, Robinson PN; N3C Consortium; RECOVER Consortium. Reese JT, et al. EBioMedicine. 2023 Jan;87:104413. doi: 10.1016/j.ebiom.2022.104413. Epub 2022 Dec 21. EBioMedicine. 2023. PMID: 36563487 Free PMC article.
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C.
Bhatia A, Preiss AJ, Xiao X, Brannock MD, Alexander GC, Chew RF, Fitzgerald M, Hill E, Kelly EP, Mehta HB, Madlock-Brown C, Wilkins KJ, Chute CG, Haendel M, Moffitt R, Pfaff ER; N3C Consortium. Bhatia A, et al. medRxiv [Preprint]. 2023 May 4:2023.05.03.23289084. doi: 10.1101/2023.05.03.23289084. medRxiv. 2023. PMID: 37205340 Free PMC article. Preprint.
881 results